FDA Officials Look to Set the Record Straight on Definition of ‘Digital Biomarker’
May 3, 2022
In an effort to address differing definitions of the term “digital biomarker” and improve discussions on drug and device development, FDA officials have penned an article meant to clear up misconceptions and spur alignment toward the agency-endorsed definition.